MiroBio, a University of Oxford spin-out, started its operations at the BioEscalator in May 2019.
The team has worked hard to produce very exciting results in the lab and has recently raised £27M in series A funding from international investors, enabling the company to scale up its team and operations. Having outgrown the BioEscalator and reached a sustainable size, the team has recently moved to The Oxford Science Park. They join another community of innovative companies, including other BioEscalator alumni.
Tim Funnell, VP, Operations of MiroBio, said: “The BioEscalator is a buzzing community of ambitious start-up biotechs and welcomed Mirobio when we were a team of just 2 people in 2019. The high-quality facilities, resources and support to grow a company were invaluable and we are now graduating as a company of 15 scientists to build our independent laboratories.”
Elodie Siney, Events and Marketing Manager, said: “MiroBio has great potential to have a huge impact on the treatment of debilitating auto-immune diseases. We wish the team all the best for the future and will follow their progress with keen interest.”